We offer FREE SHIPPPING on all orders!
We offer FREE SHIPPPING on all orders!
| THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for invitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly prohibited by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food, or cosmetic. |
Boldenone Undecylenate 200 is an injectable anabolic-androgenic steroid preparation containing 200 mg of boldenone undecylenate per milliliter. It is best known by the historical veterinary brand name Equipoise (EQ).
Boldenone is structurally related to testosterone, while the large undecylenate ester produces a particularly prolonged release profile. Unlike standard testosterone preparations, boldenone undecylenate is not FDA-approved for human therapeutic use in the United States and is principally associated with veterinary medicine.
Boldenone undecylenate consists of the anabolic steroid boldenone attached to an undecylenate ester.
The ester substantially slows the release of boldenone following injection. After ester cleavage, the active steroid is boldenone.
Boldenone itself differs structurally from testosterone through an additional double bond between carbon positions 1 and 2. Although the compounds are closely related, this modification changes boldenone's metabolism and pharmacological characteristics.
A concentration of:
Boldenone Undecylenate: 200 mg/mL
means that each milliliter contains 200 mg of the complete esterified compound.
The undecylenate ester accounts for a substantial portion of its molecular weight. Based on molecular weights, boldenone undecylenate is approximately 63% boldenone by weight.
Therefore, 200 mg of boldenone undecylenate corresponds to approximately 126 mg of boldenone, with the remainder representing the ester.
This describes chemical composition rather than an appropriate human dose.
Boldenone undecylenate is strongly associated with the veterinary product Equipoise.
Veterinary formulations have historically been used in horses and other animals for anabolic purposes, including supporting body condition.
Its veterinary history should not be interpreted as establishing safety or an accepted dosing regimen for human bodybuilding.
The undecylenate ester is considerably larger than shorter esters such as acetate or propionate.
Consequently, boldenone undecylenate has a long and gradual release profile.
This prolonged pharmacokinetic behavior also means that exposure does not disappear immediately when administration stops. The esterified drug can continue releasing boldenone for an extended period.
Exact elimination estimates vary with formulation, injection characteristics and individual pharmacokinetics, so a single fixed half-life number should not be treated as universally applicable.
After the ester is removed, boldenone binds to androgen receptors.
Androgen-receptor activation changes gene transcription in skeletal muscle and other responsive tissues.
This can influence:
Boldenone therefore possesses both anabolic and androgenic activity.
Boldenone can promote an anabolic environment through androgen-receptor-mediated effects on protein metabolism and nitrogen balance.
In bodybuilding discussions, it is frequently associated with comparatively gradual changes in lean mass rather than rapid changes in body weight.
These descriptions should not be confused with established clinical outcomes because controlled human research on nonmedical boldenone use is limited.
A gradual effect also does not mean a safer effect.
Both compounds ultimately deliver the same active steroid: boldenone.
The primary difference is the ester.
Boldenone Cypionate uses the cypionate ester and has a long release profile.
Boldenone Undecylenate uses the larger undecylenate ester and generally produces an even more prolonged release.
Because undecylenate contributes more molecular weight, an equal labeled milligram quantity also contains proportionally less boldenone than the corresponding cypionate preparation.
Boldenone is closely related to testosterone but is not simply another testosterone ester.
Testosterone is the primary endogenous male androgen and participates in numerous physiological processes involving reproductive function, sexual function, bone, muscle, blood formation and the nervous system.
Boldenone is a synthetic anabolic-androgenic steroid.
Consequently, boldenone can suppress endogenous testosterone production without serving as a complete physiological substitute for testosterone.
Boldenone is capable of aromatization, although its metabolism differs from testosterone.
It should therefore not be described as a completely non-aromatizing steroid.
Hormonal effects can become especially difficult to interpret when boldenone is combined with testosterone or other anabolic steroids.
Symptoms such as breast tenderness, fluid changes, sexual dysfunction or libido changes cannot reliably be diagnosed from the compound name alone.
Boldenone has a reputation for producing less obvious estrogen-associated water retention than substantial exposure to some aromatizing androgens.
However, visible water retention is not a reliable measure of estrogen activity or overall health risk.
A person can have significant cardiovascular or hematologic changes without appearing visibly bloated.
Boldenone retains androgenic activity.
Potential effects include:
Genetic sensitivity strongly influences these effects.
One particularly important characteristic associated with boldenone and androgen exposure generally is stimulation of erythropoiesis.
Red blood cell count, hemoglobin and hematocrit can increase.
This can sometimes become clinically significant.
An excessive hematocrit can increase blood viscosity and place additional strain on the cardiovascular system, particularly when combined with high blood pressure, dehydration, smoking, sleep apnea or other cardiovascular risk factors.
A complete blood count (CBC) can measure:
Red Blood Cell Count: Number of circulating erythrocytes.
Hemoglobin: Concentration of the oxygen-carrying protein.
Hematocrit: Percentage of blood volume occupied by red blood cells.
A substantial or persistent elevation warrants medical evaluation rather than being treated simply as evidence that the compound is "working."
Cardiovascular health is an important concern with anabolic-androgenic steroid exposure.
Potential adverse changes can include:
Total risk depends on exposure, duration, other compounds, age, genetics, blood pressure, cholesterol, smoking, sleep apnea and underlying cardiovascular health.
Boldenone can suppress the hypothalamic-pituitary-gonadal axis.
External androgen exposure creates negative feedback at the hypothalamus and pituitary.
LH and FSH production can consequently decline substantially.
Reduced LH causes the testes to decrease endogenous testosterone production.
Potential consequences include reduced natural testosterone, reduced testicular function, decreased testicular volume, changes in libido and sexual function.
Suppression of LH and FSH can also interfere with normal sperm production.
Possible consequences include:
Recovery following discontinuation varies substantially among individuals.
The particularly long ester also means the drug can continue releasing boldenone after the final administration, so stopping an injection does not immediately eliminate androgen exposure.
Boldenone is frequently associated with increased appetite in bodybuilding discussions.
Its veterinary history has also contributed to this reputation.
However, the consistency and magnitude of appetite stimulation in humans have not been established through robust controlled trials. It should therefore be considered a reported effect rather than a guaranteed pharmacological outcome.
Kidney function deserves attention during substantial anabolic-steroid exposure, particularly when blood pressure or hematocrit becomes elevated.
Interpreting serum creatinine in highly muscular individuals can be difficult because creatinine is influenced by:
Persistent kidney abnormalities, protein in the urine or uncontrolled hypertension require medical evaluation.
Boldenone undecylenate is injectable and is not a conventional 17-alpha-alkylated oral anabolic steroid.
Its hepatic profile therefore differs from oral steroids specifically modified to resist first-pass metabolism.
Nevertheless, abnormal liver enzymes or other liver abnormalities should not automatically be dismissed.
Potential injection-related complications include:
Unregulated preparations introduce additional concerns involving contamination, sterility, incorrect concentration and substitution with another compound.
Progressively worsening redness, warmth, swelling, drainage, fever or severe pain requires medical evaluation.
Potential adverse effects associated with boldenone/AAS exposure include increased hematocrit, unfavorable cholesterol changes, increased blood pressure, acne, oily skin, androgenic hair loss, suppression of endogenous testosterone, impaired fertility, sexual-function changes and injection-related complications.
Because many cardiovascular and hematologic abnormalities can initially produce few obvious symptoms, outward appearance is not a reliable indicator of safety.
Compound: Boldenone Undecylenate
Common Name: Equipoise / EQ
Common Concentration: 200 mg/mL
Drug Class: Anabolic-androgenic steroid
Active Steroid: Boldenone
Ester: Undecylenate
Release Profile: Long acting
Approximate Boldenone Content: About 126 mg boldenone per 200 mg boldenone undecylenate
Anabolic Activity: Yes
Androgenic Activity: Yes
Aromatization: Possible
Can Increase Red Blood Cell Production: Yes
Can Increase Hematocrit: Yes
Suppresses Natural Testosterone: Yes
Can Impair Fertility: Yes
Primary Established Use: Veterinary
FDA-Approved Human Use: No
Boldenone Undecylenate 200 is the long-acting boldenone preparation commonly associated with Equipoise. The large undecylenate ester provides prolonged release, while the active boldenone molecule produces anabolic and androgenic effects through androgen-receptor signaling.
Its bodybuilding reputation centers on gradual lean-tissue effects, comparatively limited visible fluid retention and reported increases in appetite. Those characteristics should not obscure its more important physiological effects.
In particular, boldenone can substantially suppress natural testosterone and fertility and can adversely affect cholesterol, blood pressure and red blood cell concentration/hematocrit. Because the undecylenate ester is long acting, exposure can also persist after administration is discontinued.
Unlike standard testosterone medications, boldenone undecylenate has no FDA-approved human therapeutic indication, and products sold for human performance use do not have an established medically accepted human dosing framework.
We do not accept returns or issue refunds for any reason, beside manufacturing defects.
Feel free to contact us if you have any questions or concerns about our Return Policy.
